BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27263239)

  • 1. Beyond and between academia and business: How Austrian biotechnology researchers describe high-tech startup companies as spaces of knowledge production.
    Fochler M
    Soc Stud Sci; 2016 Apr; 46(2):259-81. PubMed ID: 27263239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?
    Dhainaut JF; Blin O; Herry F; ; Benito S; Bilbault P; Cauterman M; Favrel-Feuillade F; Fazi-Leblanc S; Germain C; Goehrs C; Grosskopf C; Labarthe B; Lechat P; Malciu C; Marquet P; Miceli-Richard C; Peyret O; Rattenbach R; de Saint-Exupéry E
    Therapie; 2020; 75(1):113-123. PubMed ID: 31948660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Business Models in Funding the Biotech Industry: Global Trends and Challenges for Cuban Biotechnology.
    Blanco-García E
    MEDICC Rev; 2020 Jan; 22(1):11-16. PubMed ID: 32327617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational science by public biotechnology companies in the IPO "class of 2000": the impact of technological maturity.
    McNamee L; Ledley F
    PLoS One; 2013; 8(12):e82195. PubMed ID: 24358154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating "startup readiness" for researchers: case studies of research-based startups with biopharmaceutical research topics.
    Goji T; Hayashi Y; Sakata I
    Heliyon; 2020 Jun; 6(6):e04160. PubMed ID: 32577559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swiss Startup Framework: A Highly Effective Network Supporting the Generation of Emerging Biotech Businesses.
    Mitchell I; Steiner S; Altorfer M; Suter-Dick L
    Chimia (Aarau); 2020 Oct; 74(10):765-767. PubMed ID: 33115556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From spare change to real change. The social sector as beta site for business innovation.
    Kanter RM
    Harv Bus Rev; 1999; 77(3):122-32, 210. PubMed ID: 10387574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Space: the final frontier.
    Medenbach JJ
    Nat Biotechnol; 2005 Nov; 23(11):1339-41. PubMed ID: 16333871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotechnology and new companies arising from academia.
    Vallance P
    Lancet; 2001 Nov; 358(9295):1804-6. PubMed ID: 11734259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can science be a business? Lessons from biotech.
    Pisano GP
    Harv Bus Rev; 2006 Oct; 84(10):114-24, 150. PubMed ID: 17040044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Back to basics: from industry to academia.
    Powell K
    Nature; 2004 Aug; 430(7000):706-7. PubMed ID: 15295606
    [No Abstract]   [Full Text] [Related]  

  • 13. Networking, networking, networking, networking, networking.
    Watanabe M
    Nature; 2004 Aug; 430(7001):812-3. PubMed ID: 15306820
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel maturity index for assessing medical device startups.
    Richmond FJ; Zapotoczny G; Green B; Lokappa S; Rudnick K; Espinoza J;
    J Clin Transl Sci; 2022; 6(1):e99. PubMed ID: 36106131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploitation of biotechnology in a smaller company.
    Fairtlough GH
    Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):589-97. PubMed ID: 2573092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between academic institutions and industry in the life sciences--an industry survey.
    Blumenthal D; Causino N; Campbell E; Louis KS
    N Engl J Med; 1996 Feb; 334(6):368-73. PubMed ID: 8538709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovation in biotechnology: moving from academic research to product development--the case of biosensors.
    Siontorou CG; Batzias FA
    Crit Rev Biotechnol; 2010 Jun; 30(2):79-98. PubMed ID: 20214418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three researchers developing therapies based on RNA interference talk about their experiences leaving academia for biotech companies.
    Bonetta L
    Biotechniques; 2007 Apr; 42(4 Suppl):S10-11, S16. PubMed ID: 18798733
    [No Abstract]   [Full Text] [Related]  

  • 19. Research, policy and funding - academic treadmills and the squeeze on intellectual spaces.
    Smith K
    Br J Sociol; 2010 Mar; 61(1):176-95. PubMed ID: 20377602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotechnology in South Africa.
    Cloete TE; Nel LH; Theron J
    Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.